Summary.-Using the DMBA-induced mammary tumour as a model, the effect of hormone manipulation on steroid sulphurylation and on oxidative and reductive metabolism has been investigated. or oestradiol-17p + progesterone, administered to oophorectomized animals, had no effect on adenosine-3'-phosphate-5'-phosphosulphate formation in the tumours. Dehydroepiandrosterone sulphotransferase was also unaffected. A large increase in oestrogen sulphotransferase following administration of oestrogen + progesterone was observed in some but not all tumours, and the overall results were not statistically significant. The major metabolities of dehydroepiandrosterone, by both human and carcinogen-induced rat mammary tumours in vitro, are 7-oxygenated derivatives. Oestrogen administration led to a significantly decreased production of total 7-oxygenated derivatives of dehydroepiandrosterone. Conversion to 5-androstene-3p,17p-diol was unaffected by the hormones. The rate of formation of oestradiol-17p from oestrone was increased 5-fold in growing tumours from animals receiving oestrogen, or oestrogen+proges-terone, compared to regressing tumours in oophorectomized control animals.
A HYPOTHESIS has been presented implicating adrenal dehydroepiandrosterone (DHEA) and DHEA sulphate (DHEAS) in the aetiology of human breast cancer (Adams, 1977) . The main metabolites of DHEA, produced by in vitro incubation with human mammary tumours, are 7-oxygenated derivatives (7a-hydroxy DH-EA, 7P-hydroxy and 5-androstene-3g, 17/-diol (Li et al., 1978) . The latter can cause translocation of the oestrogen receptor in both the uterus and mammary tumours Nicholson et al., 1978) . Although it is difficult to be certain of the exact role played by the 7-hydroxylation system in mammary tissue, it has been suggested ) that it could function as an inactivation step to modify oestrogen receptor translocation by 33-hydroxy-A5-androstenes, which are known to occur in relatively high concentrations in human mammary tumours (Maynard et al., 1977) . Thus high levels of DHEAS in the blood could lead to high intracellular levels of DHEA and its metabolites formed in situ in mammary tissue.
Pathways of DHEA metabolism similar to those established in human mammary tumours also occur in 7,12-dimethylbenz-(a)anthracene (DMBA)-induced rat mammary tumours (Li et al., 1976) . It was thus of interest to use this as a model to study the influence of an altered sexhormone milieu in tumour-bearing rats upon subsequent DHEA metabolism in the tumour. In parallel studies, the influence of an altered hormone milieu on oestrogen metabolism by these tumours has been investigated.
One other aspect of DHEA metabolism by human mammary tumours, i.e. formation of the sulphate ester, is of relevance when considered together with the sulphurylation of oestradiol-17/. Measurement of these conversions by the tumour in vitro has been shown to relate to the patient's subsequent prognosis (Dao & Libby, 1972 (Dao & Libby, 1972) . Counts in the controls were subtracted. and the net counts expressed as pmol of steroid sulphate/mg protein/h. DHEA metabolism.-Incubation of finely minced tumour tissue (0 5 g) in 2 ml of modified Krebs-Ringer phosphate buffer (pH 7.4) wN-ith [4-14C] dehydroepiandrosterone (0 5 , uCi) and an NADPH-generating system was carried out as described by Li et al. (1978) . Products were extracted, separated, deter-mined and characterized as described in previous publications (Li et al., 1976 (Li et al., , 1978 Liquid-scintillation counting.-This was carried out using a Triton-toluene phosphor system as described by Li et al. (1978) min and then the concentration remained static. This is shown in the Figure and was typical of the data obtained with 4 separate tumours. In Table I , values listed under "PAPS" represent the sum of PAPS + APS, or the "PAPS potential" assayed after 30 min. Oestrogen alone, or oestrogen followed by progesterone, had no significant influence, either on PAPS potential or on the actual PAPS values (not shown). DHEA sulphotransferase activity was unaltered by hormone administration. In contrast, oestrogen alone, or more especially oestrogen + progesterone, led to an increase in the mean oestrogen sulphotransferase activity, which was 4-fold when progesterone was included. However, owing to the variability between tumours, these results were not significant (Group 3 vs Group 1, P < 0 1, Table I ). Tumours from oophorectomized animals (Group 1) generally showed degenerative regressional changes on histological examination. These changes occurred mostly in the form of pools of mucinous material deposited in the lobular units. In some tumours, the lobular units had lost their distinct architectural form and showed diffuse infiltration of the connective tissue. Tumours from animals receiving oestrogen (Group 2) were generally more cellular, the mucinous material had largely disappeared and infiltration of the connective tissue was common. Oestrogen + progesterone (Group 3) led to tumours with a higher degree of structural organization and an increased secretion of PAS+ material. The stroma of tumours from Groups I and 2 showed considerable variegation, and in some cases diffuse inflammatory response with the presence of mast cells.
Metabolism of [4-14C] DHEA and [4-14C] oestrone
Major products of the in vitro metabolism of DHEA by rat mammary tumours were previously shown to be 7ac-and 73-hydroxy DHEA, 7-oxo DHEA and 5-androstene-3/,17/3-diol (Li et al., 1976) . Oestrogen administration to oophorectomized rats led to a drop in each of the 7-oxygenated products of DHEA. Although the total 7-oxygenated products were significantly reduced by some 37 % (P < 0 02) by oestrogen administration, reduced formation of the main component, 7a-hydroxy DHEA, was not significant (P <0 2). Progesterone tended to reverse the effects of oestrogen, as judged by formation of total 7-oxygenated products (Table II) (Table II) .
DISCUSSION
Levels of steroid sulphotransferases in human mammary tumours have been shown to relate to the overall prognosis of the patient, and to the response to hormone ablation (Dao & Libby, 1972) . The ability of an individual tumour to generate sufficiently high concentrations of PAPS plays a dominant role in the determination of the degree of sulphurylation of steroids added to the incubations of the tumour extracts (Dao & Libby, 1972; Li et al., 1976; Adams & Chandra, 1977) . From data of the type presented in the Figure, it was calculated that the concentration of PAPS in the incubations with tumour cytosol preparations would only reach 1-2 tM. The Km for PAPS, using purified bovine placental oestrogen sulphotransferase, is 37 pM (Adams et al., 1974) and the corresponding values and DHEA sulphotransferase are 13 /M for enzyme from rat liver and 20 /tM for enzyme from bovine liver (Adams & McDonald, unpublished) . Thus, assay of oestrogen and 3/-hydroxysteroid sulphotransferases were carried out by addition of saturating concentrations of the cosubstrate PAPS. The specific increase in oestrogen sulphotransferase by progesterone (Table I) , although not significant in the present experiments, is comparable to a similar influence of this hormone on the enzyme in the endometrium in the gilt (Pack & Brooks, 1974) and human (Buirchell & Hahnel, 1975) uterus. In these cases, the enzyme is induced by progesterone at the end of the proliferative phase of the oestrous and menstrual cycles, and appears to regulate the localized concentration of oestrogen by conversion to the water-soluble inactive conjugate. In the DMBA tumour progesterone may play a similar role, and would provide another example of a "modifying" effect of progesterone on oestrogen action. Although progesterone administration led to large increases in the activity of oestrogen sulphotransferase in some tumours, the effect was not consistent, and the results were not statistically significant. The reason for this is unknown. No apparent differences were noted on histological examination oftumour sections, and rates of tumour regression after oophorectomy were similar, and did not explain the variance in oestrogen sulphotransferase levels.
In mammary tumours from the rat (Li et al., 1976) and human (Couch et al., 1975; Li et al., 1978) 7-oxygenated products are the main metabolites formed from IDHEA in vitro. It has been established that these conversions are catalysed by enzymes, and are not due to chemical oxidation at the active methylene group at position 7 in 5-androstenes (Li et al., 1976) . In an extensive series of experi-9 ments, no evidence was found that 7-hydroxy DHEA synthesis represented an intermediate in a more elaborate biosynthetic pathway (Li & Adams, unpublished) . However, the presence of the 7-hydroxyl group in 3/-hydroxy-A5-steroids does convey certain properties which suggest that the 7-hydroxylase may play an important role in the cell. For example, introduction of the 7-hydroxyl group into 5-androstene-33,17/-diol markedly reduced this steroid's capacity to combine with the oestrogen receptor (Li et al., 1978) . In addition, the ability of DHEA and 5-androstene-3/,17P-diol to inhibit oestrogen sulphotransferase was nullified by 7-hydroxylation .
Although oestrogen administration did significantly lower formation of 7-oxygenated derivatives of DHEA, the effect was not pronounced. In rat liver, the 7-hydroxylase for DHEA has unusual properties compared to other steroid hydroxylases. It appears to fall more in the class of a "constitutive" enzyme, since it is present in the liver of sexually immature males and females and, in contrast to 16oz-hydroxylase, the presence of androgen at a critical period of neonatal life is not needed for expression of the enzyme in the liver (Tabei & Heinrichs, 1974) . Both 7ac-and 16oz-hydroxylases for DHEA in adult male rat liver are sensitive to light/ dark modulations, and it has been suggested that the 7cx-hydroxylase is adrenaldependent, rather than both gonad-and adrenal-dependent, as is the case of the 16a-hydroxylase (Schafer & Colas, 1975) . The 17/-hydrogenation of DHEA to 5-androstene-3p,173-diol was unaffected by hormone administration (Table II) which appears to reflect the situation in rat liver; this transformation being unaffected by castration in either sex (Tabei & Heinrichs, 1974) .
Mammary tumours whose growth was stimulated by oestrogen, or oestrogen + progesterone, showed a greater capacity to convert oestrone to oestradiol-17/ than regressing tumours (Table II) . In vitro studies have shown that human mammary tumours cultured in the presence of either labelled oestrone or oestradiol-173 showed higher ratios of oestradiol-17,B to oestrone than did normal or benign tissues (Willcox & Thomas, 1972; Geier et al., 1975) . The specific activities of oestradiol-178 dehydrogenase in subcellular fractions of breast-cancer tissues are lower than those from non-malignant tissue (Pollow et al., 1977) . Thus, whilst a decrease in oestradiol-17/ dehydrogenase could explain the decrease in oestradiol-17/ metabolism in neoplastic mammary tissue, it is inconsistent with the observed higher conversions of oestrone to oestradiol-17,. King et al. (1965) made the interesting observation that faster-growing DMBAinduced rat mammary tumours converted oestrone to oestradiol at a greater rate than slower-growing tumours. One explanation for the in vitro results obtained with DMBA-induced tumours (Table II) and the human tumours referred to above, could be an altered redox state of pyrimidine nucleotides. There is well-documented evidence that oestradiol-17, induces glucose-6-phosphate dehydrogenase (GPDH) in both normal and neoplastic mammary tissue (Hilf et al., 1967; Ringler & Hilf, 1975) . Furthermore, GPDH activity is higher in neoplastic tissue (Smith et al., 1966; Knox, 1967; Richards & Hilf, 1972) and neoplastic mammary tissue contains higher oestrogen-receptor concentrations than normal mammary tissue, thus suggesting a correlation between GPDH and oestrogen receptor (Daehnfeldt & Schulein, 1975 ). An increase in NADPH/NADP+, via raised GPDH levels, could then account for the increase in the rate of oestradiol-17, formation from oestrone in DMBA-induced tumours after oestrogen administration to oophorectomized animals.
